National Institute on Drug Abuse
Division of Treatment Research and Development
Chemistry and Pharmaceutics Branch
Branch Functions
- To administer a national program of research and development in the following areas:
- medicinal chemistry focusing on design and synthesis of new chemical candidates with pharmacotherapeutic potential. Applications of molecular modeling, combinational techniques, and natural product approaches are points of special focus.
- bioavailability, pharmacokinetics, drug metabolism studies, and studies on the interactions of these compounds with known drugs of abuse, including fetal exposure
- To develop and manage resources for bulk chemical preparation and dosage form preparation of medications under development and carried out in compliance with the FDA Good Manufacturing Practice (GMP) regulations
- To provide analytical chemistry development and services, including the development of assay methods for applications of drug characterization bioavailability and kinetic studies in the Division. To provide a centralized analysis resource for biological specimens (e.g., urine for cocaine use detection).
- To manage the distribution of controlled substances and related compounds, research chemicals, bulk pharmaceuticals, and dosage forms that are used in programs associated with medications development
- To provide documentation for the testing of new drug substances and dosage forms for Investigational New Drug applications (INDs) and New Drug Application (NDA) reports for drugs developed in the Division.
- To provide consultation and technical support for urine testing of drugs of abuse in clinical trials being conducted for the Division.
|
|